ArticleTranslational andrology and urology2024

The final report of KEYNOTE-426 showed the efficacy and safety as a treatment for advanced renal cell carcinoma.

Kojiro Ohba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.